Recent advances in treatment of cerebral ischemic stroke

Ischemic stroke occurs when there is an obstruction or collapse of a blood vessel in the head or neck, which causes a lack of oxygen to the brain. Due to the lack of oxygen, detrimental motor and sensory deficits transpire in the areas of the brain that are affected. When an individual suffers an ischemic stroke, there is a specific time window and treatment regimen that is used to manage symptoms of a stroke. The principal concerns with stroke treatments are that don’t fully recover motor and sensory function lost during a stroke occurrence. With the use of stem cells from several sources, they can be reprogrammed and transplanted into the brain to facilitate full recovery of motor and sensory function. The purpose of this review article is to investigate the precursors, diagnostic methods, treatment techniques and new stem cell treatment research associated with ischemic stroke in anticipation to cure cognitive, sensory and motor dysfunction.

PDF

___

1. Guzik A, & Bushnell C. Stroke epidemiology and risk factor management. CONTINUUM: Lifelong Learn in Neuro. 2017;23:15–39.

2. Randolph S. A. Ischemic Stroke. Workplace Health & Safety. 2016;64, 444.

3. Allaoui A, Echchilali K, Moudatir M, et al. Etiologies des accidents vasculaires cérébraux ischémiques chez les jeunes: apport de l’interniste. Pan African Med J. 2018;30:114.

4. Howard G, Kleindorfer DO, Cushman M, et al. Contributors to the excess stroke mortality in rural areas in the united states. Stroke. 2017;48:1773–8.

5. Caldwell M, Martinez L, Foster J, et al. Prospects for the Primary Prevention of Myocardial Infarction and Stroke. J Cardio Phar Thera. 2019;24:207–14.

6. Rupal O, Kristen R, and Miriam G. Recurrent Ischemic Stroke: Strategies for Prevention. Am Fam Phys. 2017 Oct 1;96:436–40.

7. Faure M, Castilloux A, Lillo‐Le‐Louet A, et al. Secondary stroke prevention: a population‐based cohort study on anticoagulation and antiplatelet treatments, and the risk of death or recurrence. Clinic Phar Thera. 2019; 107:443-51.

8. Musuka TD, Wilton SB, Traboulsi M, et al. Diagnosis and management of acute ischemic stroke: speed is critical. CMAJ: Canadian Medical Association journal. J de l'Association med canadienne. 2015;187:887–93.

9. Masdeu JC, and Ramón GG. Neuroimaging. Amsterdam: Elsevier. 2016. 10. Kokaia Z, Tornero D, and Lindvall O. Transplantation of reprogrammed neurons for improved recovery after stroke. Prog Brain Res. 2017;231:245- 63.

11. Loubinoux I, Demain B, Davoust C, et al. Stem cells and motor recovery after stroke. Annals Phy Reh Med. 2014;57:499–508.

12. Sacco RL, Kasner SE, Broderick JP, et al. Council on Nutrition, Physical Activity and Metabolism. An updated definition of stroke for the 21st century: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:2064–89.

13. Adams HP, and Biller J. Classification of Subtypes of Ischemic Stroke: History of the Trial of Org 10 172 in Acute Stroke Treatment Classification. Stroke. 2015;46:114–7.

14. Béjot Y, Daubail B, and Giroud M. Epidemiology of stroke and transient ischemic attacks: Current knowledge and perspectives. Revue Neuro. 2016;172:59–68.

15. Toni D, Di Angelantonio E, Di Mascio MT, et al. Types of Stroke Recurrence in Patients with Ischemic Stroke: A Substudy from the PRoFESS Trial. Int J Stroke. 2013;9,873–8.

16. Mair G, and Wardlaw JM. Imaging of acute stroke prior to treatment: current practice and evolving techniques. The British J Radio. 2014;87:20140216.

17. Smith WS, and Furlan AJ. Brief History of Endovascular Acute Ischemic Stroke Treatment. Stroke. 2016;47.

18. Cruz-Flores S. Acute Stroke and Transient Ischemic Attack in the Outpatient Clinic. Medical Clinics of North America.2017;101:479–94.

19. MacGregor EA. Migraine and female hormones - what factors increase the risk of ischemic stroke? Vascular Med. 2000;5:113–33.

20. Errata: Vol. 66 No. 34. Morbidity and Mortality Weekly Report (MMWR). CDC. 2017;66:1030.

21. Baltan S. Stroke in CNS white matter: Models and mechanisms 2019. Neuroscience Letters. 2019;711:134411.

22. Della-Morte D, Guadagni F, Palmirotta R, et al. Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments. Pharmacogenomics. 2012;13:595–613.

23. Rodrigo R, Fernandez-Gajardo R, Gutiérrez R, et al. Oxidative Stress and Pathophysiology of Ischemic Stroke: Novel Therapeutic Opportunities. CNS & neurological disorders drug targets. 2013;12:698-714.

24. Griendling KK, Touyz RM, Zweier JL, et al. Measurement of Reactive Oxygen Species, Reactive Nitrogen Species, and Redox-Dependent Signaling in the Cardiovascular System: A Scientific Statement From the American Heart Association. Circulation research. 2016;119:39-75.

25. Griffis JC, Metcalf NV, Corbetta M, et al. Structural disconnections explain brain network dysfunction after stroke. Cell reports. 2019;28:2527–40.

26. Wang S, Zhang H, and Xu Y. Crosstalk between microglia and T cells contributes to brain damage and recovery after ischemic stroke. Neurological research. 2016;38:495-503.

27. Wolf SA, Boddeke HW, and Kettenmann H. Microglia in Physiology and Disease. Annual Rev Phy. 2017;79:619–43.

28. Erbguth F. Stroke Mimics und Stroke Chamäleons – Differenzialdiagnose des Schlaganfalls. Fortschritte Der Neurologie. Psychiatrie. 2017;85:747– 64.

29. Savić T, Gambino G, Bokharaie VS, et al. Early detection and monitoring of cerebral ischemia using calcium-responsive MRI probes. Proceedings of the National Academy of Sciences. 2019;116:20666-20671.

30. Yew KS, and Cheng E. Acute stroke diagnosis. American family physician. 2009;80:33–40.

31. Zong X, Dong Y, Li Y, et al. Beneficial effects of theta-burst transcranial magnetic stimulation on stroke injury via improving neuronal microenvironment and mitochondrial integrity. Trans Stroke Res. 2019;11:450–67.

32. Itoh H, and Saeki S. Transcranial direct current stimulation for improving upper limb function after stroke. Japanese Journal of Stroke. 2019;41:523- 8.

33. MacKay-Lyons M, Billinger SA, Eng JJ, et al. Aerobic Exercise Recommendations to Optimize Best Practices in Care After Stroke: AEROBICS 2019 Update. Phy Thera. 2019;00:149–56.

34. Powers WJ, Derdeyn CP, Biller J, et al. 2015 American heart association/ american stroke association focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment. Stroke. 2005;46:3020–35.

35. Arsava E. M, Kim GM, Oliveira-Filho J, et al. Prediction of Early Recurrence After Acute Ischemic Stroke. JAMA Neurology. 2016;73:396.

36. Kawada T. Factors of recurrence in patients with ischemic stroke or TIA. Acta Neuro Scandinavica. 2019;141:258.

37. Ay H, Gungor L, Arsava EM, et al. A score to predict early risk of recurrence after ischemic stroke. Neuro. 2009;74:128–35.

38. Kauw F, Takx R, de Jong H, et al. Clinical and Imaging Predictors of Recurrent Ischemic Stroke: A Systematic Review and Meta-Analysis. Cerebrovasc Dis. 2018;279-87.

39. Diener HC, Bernstein R, and Hart R. Secondary Stroke Prevention in Cryptogenic Stroke and Embolic Stroke of Undetermined Source (ESUS). Curr Neurol Neurosci Rep. 2017;17:64.

40. Nito C, Sowa K, Nakajima M, et al. Transplantation of human dental pulp stem cells ameliorates brain damage following acute cerebral ischemia. Biomedicine & Pharmacotherapy. 2018;108:1005–14.